Search

everythinglearnresearchcommunity

for

Search:↓

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

PCOS involves immune and genetic factors, with key roles for T cells and specific genes.

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Developing human skin has immune cells with memory-like features.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Blocking LFA-1 prevents hair loss in mice.

Thymoma with alopecia areata may be linked to abnormal immune cells.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Innate lymphoid cells help us understand and manage allergic diseases better.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Early regulatory T cells are crucial for normal skin pigmentation.